Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Sphingosine-1-phosphate (S1P) receptor modulators & Ulcerative colitis (UC)

Navigation

Contents

Using Sphingosine-1-phosphate (S1P) receptor modulators (L04AE) represents a new therapeutic option for ulcerative colitis patients
Wils & Peyrin-Biroulet 2023 Immunotherapy 15(5): 311-321

see also:
Etrasimod & Ulcerative colitis (UC)
Ozanimod & Ulcerative Colitis (UC)
Sphingosine-1-phosphate (S1P) receptor modulators & Inflammatory Bowel Disease (IBD)

References (Sources)

Etrasimod for the treatment of ulcerative colitis
Wils & Peyrin-Biroulet 2023 Immunotherapy 15(5): 311-321
Review
Sphingosine-1 Phosphate Receptor Modulators: The Next Wave of Oral Therapies in Inflammatory Bowel Disease
Choden et al. 2022 Gastroenterol Hepatol (NY) 18(5): 265-271
Sphingosine-1-Phosphate Receptor Modulators for the Treatment of Ulcerative Colitis: A Narrative Review Focusing on Safety
Fantini et al. 2025 United European Gastroenterol J 13: 1077-1091
Review
The Current Sphingosine 1 Phosphate Receptor Modulators in the Management of Ulcerative Colitis
Choon et al. 2025 J Clin Med 14: 3475
Review

AI Chat

11/5/2026

Chat with our artificial intelligence: